Explore All 400 Growth Capital Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | December 9, 2022 |
| Target | George Clinical |
| Sector | Life Science |
| Investor(s) | Hillhouse |
| Deal Type | Growth Capital |
| Advisor(s) | BofA Securities Lazard (Financial) Herbert Smith Freehills (Legal) |
FILTER BY
Hillhouse Capital Management is a private investment firm focused on opportunities throughout Asia. The Firm will invest at all company stages, including seed investments, buyouts, and listed equities. Areas of interest include consumer and health. Hillhouse Capital Management is based in Hong Kong.
| Deal Context for Investor | # |
|---|---|
| Overall | 11 of 12 |
| Sector: Life Science | 2 of 2 |
| Type: Growth Capital | 2 of 2 |
| Country: Australia | 1 of 1 |
| Year: 2022 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-08-25 |
AI Dream
Shanghai, China AI Dream is a branded sleep solution provider and one of the largest players in China’s premium mattress market. Its differentiated product offering includes mattresses, bed frames, smart beds, and customized bedroom solutions. AI Dream was founded in 2018 and is based in Shanghai, China. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-12-28 |
SK eco prime
Seoul, South Korea SK eco prime is an eco-friendly bioenergy company, that creates bioenergy products using our world-class technology and supply them to customers. SK eco prime was founded in 2007 and is based in Seoul, South Korea. |
Buy | - |
